Global News

Proteus and Otsuka to develop novel digital health products

Friday, July 6, 2012 11:24 AM

Proteus Digital Health, developer of wearable and ingestible sensor technology, and Otsuka Pharmaceutical, a global healthcare company based in Japan, have entered into an exclusive worldwide license and collaboration agreement to develop and commercialize a new category of medicines.

More... »

Sanofi to divest its stake in the Yves Rocher Group

Thursday, July 5, 2012 02:21 PM

Global pharmaceutical company Sanofi has divested its direct and indirect stake of approximately 19.3% in the Yves Rocher Group, a company focused on cosmetics, home care products and clothing, to Société Financière des Laboratoires de Cosmétologie Yves Rocher, subject to certain closing conditions.

More... »

Genstar Capital completes ERT acquisition

Thursday, July 5, 2012 09:12 AM

Genstar Capital, a private equity firm, has completed its acquisition of ERT, a global technology-driven provider of health outcomes, in a take-private transaction valued at approximately $400 million.

More... »

Icon appoints three to senior clinical and laboratory positions

Tuesday, July 3, 2012 10:49 AM

Icon,a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, has appointed three additions to the senior management teams of its clinical and central laboratories businesses.

More... »

Sorin Group acquires CalMed for $14M

Tuesday, July 3, 2012 10:14 AM

Sorin Group, a global medical device company with a focus on cardiovascular diseases, has acquired California Medical Laboratories (CalMed), a manufacturer of high quality cardiovascular cannulae, for $14 million.

More... »

Numerate integrates platform with Google Compute Engine

Tuesday, July 3, 2012 09:36 AM

Numerate, a technology platform company that uses proprietary algorithms and cloud computing to transform the drug design process, has integrated its platform with Google Compute Engine.

More... »

GSK, Theravance report positive results from four phase III COPD studies

Monday, July 2, 2012 03:09 PM

GlaxoSmithKline and Theravance, a biopharmaceutical company based in San Francisco, issued results from four pivotal phase III studies of investigational LAMA/LABA involving over 4,000 patients with chronic obstructive pulmonary disease (COPD).

More... »

Almac launches mobile web site

Monday, July 2, 2012 12:25 PM

Almac launched a mobile optimized version of its web site, enabling biotech and pharma clients and prospective customers to access Almac’s content while out of the office with only a smartphone in hand.

More... »

OTTLIV names winners of first Innovation Trophies

Monday, July 2, 2012 12:04 PM

OTTLIV, the technology transfer arm of Assistance Publique-Hopitaux de Paris (AP-HP), a network of 37 Paris hospitals and universities, has announced the results of the first Innovation Trophies, designed to mark outstanding promise resulting from research within AP-HP.

More... »

BMS acquires Amylin Pharmaceuticals, expands diabetes alliance with AZ

Monday, July 2, 2012 09:59 AM

Global biopharmaceutical company Bristol-Myers Squibb (BMS) has agreed to acquire Amylin Pharmaceuticals of San Diego for $31.00 per share in cash, pursuant to a cash tender offer and second step merger, or an aggregate purchase price of approximately $5.3 billion.

More... »